UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
98 hedge funds and large institutions have $83.8M invested in Unity Biotechnology in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.41% less ownership
Funds ownership: 3.71% → 3.3% (-0.41%)
31% less capital invested
Capital invested by funds: $122M → $83.8M (-$38M)
33% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 24
Holders
98
Holding in Top 10
3
Calls
$1.41M
Puts
$474K
Top Buyers
| 1 | +$3.47M | |
| 2 | +$2.81M | |
| 3 | +$2.38M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.07M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$1.06M |
Top Sellers
| 1 | -$9.1M | |
| 2 | -$6.95M | |
| 3 | -$2.29M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.42M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.15M |